MORE►
National Institutes of Health
University of North Texas President Neal Smatresk. [Image sources: Smatresk, Gary Payne/UNT Photo; background, DI Studio]
Next Chapter: University of North Texas President Neal Smatresk Announces Plans to Step Down
by Quincy Preston | Feb 6, 2024
Neal Smatresk's decade at UNT sparked big changes and growth, boosting its standing in academics and research. From "record-breaking enrollment" to "making UNT the highest-ranked Tier One institution in the North Texas region," his tenure marks transformation across multiple fronts.
by Lance Murray |
Jun 22, 2023
"There are over 10,000 rare diseases that affect millions of people worldwide, and most of them are genetic," notes UT Southwestern's Steven Gray (above, with Susan Iannaccone, M.D.). Testing on a total of eight genetic diseases has been approved for funding by the Bespoke Gene Therapy Consortium and other organizations.
MORE►
by David Seeley |
Apr 20, 2023
According to the NIH, up to 5% of people worldwide have improperly aligned eyesight—a condition known as strabismus. An even higher percentage of people suffer from computer vision syndrome—digital eye strain caused by prolonged use of digital devices. Today Neurolens announced a milestone in alleviating the conditions' symptoms, seven months after raising $67 million to fund the company's growth.
MORE►
by Lance Murray |
Feb 21, 2023
The UT Southwestern researchers discovered the first molecular biomarker for AGL, a rare disorder in which fat deposits are destroyed, causing patients to have dangerously low body fat, signs of accelerated aging, and severe metabolic diseases including diabetes and fatty liver.
MORE►
Drs. Rhonda Bassel-Duby, Takahiko Nishiyama, and Eric Olson of UT Southwestern. [Photo: UTSW]
UT Southwestern Team’s Gene Editing Battles 1-in-250 Heart Condition
by Lance Murray | Dec 21, 2022
UT Southwestern researchers have used gene editing technology to develop what could be a breakthrough for dilated cardiomyopathy, a heart condition that affects one in 250 people worldwide.
“The pace of this field is really breathtaking,” said Eric Olson, Ph.D., who co-led the study. “I expect that if this moves forward into patients, we’re not talking within decades—we’re talking within years.”
MORE►
by Lance Murray |
Nov 9, 2022
The Perot family’s support will expand the number of students admitted to UT Southwestern's dual-degree program as well as research disciplines in which they study, to include biomedical engineering, computational biology, bioinformatics, and data science.
The funding will enhance the curriculum and experiences of Medical Scientist Training Program students and increase efforts to recruit students from elite U.S. colleges, including top international students who want to stay in the U.S. for their careers.
MORE►
by Kevin Cummings |
Oct 18, 2022
Dallas-based Nanoscope Therapeutics is accelerating the development of therapies that could restore sight in patients with the help of a publicly traded firm. The retinal degenerative diseases-focused biotech company announced a new gene therapy manufacturing partnership with contract research organization Charles River Laboratories International.
MORE►
by Kevin Cummings |
Oct 17, 2022
In this week’s North Texas deal flow, you’ll also find news about Mavenir’s $155M raise, Pinnacle Realty Advisors raising $5M for ‘brokerage-as-a-service’ platform, Exela Technologies taking its European business unit public, American Airlines’ hydrogen fuel distribution investment, and more.
MORE►
Dell's Erik Day, Spark Biomedical's Daniel Powell, and The DEC's Bill Chinn [Photo: Tres Cox]
Dallas Medical Device Company Wins Top Prize at Dell for Startups Pitch Competition
by Kevin Cummings | Aug 9, 2022
“Opioids are diabolical, because they actually change the structure and function of your brain; they change the way your reward system works,” said Daniel Powell, CEO at Spark Biomedical.
Meet Powell and six other startup leaders.
Meet Powell and six other startup leaders.
MORE►
by Kevin Cummings |
Jul 25, 2022
Plus, Fort Worth's Harvest Returns raises new fund; new Ryan acquisition makes 2022 its most active M&A year; OpTic Gaming acquires Dallas chatbot startup; Dallas legal education firm boosts digital content library; and Fort Worth's Novaria Group acquires firm with giant aerospace clients.
MORE►
by Kevin Cummings |
Jul 20, 2022
UT Dallas-based Qualia Oto is developing the next generation of cochlear implants, and has announced closing a Series A preferred round of around $1.64 million.
Unlike typical cochlear implants that use bundles of wires attached to a receiver to stimulate the auditory nerve, Qualia Oto’s implant uses thin-film electrode arrays embedded in a polymer, allowing for more contact with the inner ear. That translates to a higher quality and range of sounds that are able to be transmitted.
MORE►
by Kevin Cummings |
May 12, 2022
AyuVis, an immunotherapy startup, is set to get a $1.8 million Small Business Innovation Research grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funding will support the pre-clinical research of its drug candidate to treat the second-leading cause of death in premature babies.
Founder Suchismita Acharya calls the timing "perfect."
Founder Suchismita Acharya calls the timing "perfect."
MORE►
Photo: typhoonski/iStockPhoto
Dallas to Host Federal BioTech Conference
by Dave Moore | Apr 27, 2018
Local startups and researchers can learn how to get federal research-and-tech-driven grant funding and meet federal experts in this conference hosted by the Dallas Regional Chamber.
MORE►
by Lance Murray |
Oct 23, 2017
Nexeon shares are trading over the counter as the company moves forward with advanced medical systems.
MORE►
by Lance Murray |
Aug 10, 2017
The institutions were evaluated based on the number of published research articles cited as major sources of third-party patent applications.
MORE►
by Lance Murray |
May 16, 2017
Francis S. Collins led the Human Genome Project before taking the reins at the National Institutes of Health.
MORE►
